Goldman Sachs
USNA icon

Goldman Sachs’s Usana Health Sciences USNA Stock Holding History

Goldman Sachs’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-45,000
Closed -$1.95M – 6804
2013
Q3 		$1.95M Buy
+45,000
New +$1.81M ﹤0.01% 3940

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs's USNA Position: Q2 2026 in Review

Goldman Sachs increased its Usana Health Sciences (USNA) stake by 35% in Q2 2026, buying an estimated $604K and bringing the position to 123,267 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #4458.

Goldman Sachs first reported a position in USNA in Q2 2013 and has held it in 53 quarters since. The position peaked at $22.3M in Q2 2018. 137 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Goldman Sachs held 123,267 shares of Usana Health Sciences worth $2.63M as of Q2 2026.
  • Goldman Sachs bought 32,118 Usana Health Sciences shares in Q2 2026, an estimated $604K.
  • Usana Health Sciences made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4458 holding.
  • Goldman Sachs first reported a position in Usana Health Sciences in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Usana Health Sciences position peaked at $22.3M in Q2 2018.
  • 137 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.